Augmedix Current Valuation vs. Price To Book

AUGXDelisted Stock  USD 2.35  0.00  0.00%   
Based on the key profitability measurements obtained from Augmedix's financial statements, Augmedix may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Augmedix's ability to earn profits and add value for shareholders.
For Augmedix profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Augmedix to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Augmedix utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Augmedix's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Augmedix over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Please note, there is a significant difference between Augmedix's value and its price as these two are different measures arrived at by different means. Investors typically determine if Augmedix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Augmedix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Augmedix Price To Book vs. Current Valuation Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Augmedix's current stock value. Our valuation model uses many indicators to compare Augmedix value to that of its competitors to determine the firm's financial worth.
Augmedix is the top company in current valuation category among its peers. It also is number one stock in price to book category among its peers . The ratio of Current Valuation to Price To Book for Augmedix is about  10,208,473 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Augmedix's earnings, one of the primary drivers of an investment's value.

Augmedix Current Valuation vs. Competition

Augmedix is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is presently estimated at about 141.43 Million. Augmedix totals roughly 113.21 Million in current valuation claiming about 80% of equities under Health Care industry.

Augmedix Price To Book vs. Current Valuation

Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Augmedix

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
113.21 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Augmedix

P/B

 = 

MV Per Share

BV Per Share

 = 
11.09 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

Augmedix Price To Book Comparison

Augmedix is currently under evaluation in price to book category among its peers.

Augmedix Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Augmedix, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Augmedix will eventually generate negative long term returns. The profitability progress is the general direction of Augmedix's change in net profit over the period of time. It can combine multiple indicators of Augmedix, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Augmedix, Inc. provides remote medical documentation solutions and live clinical support services in the United States. The company was founded in 2013 and is headquartered in San Francisco, California. Augmedix operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 706 people.

Augmedix Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Augmedix. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Augmedix position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Augmedix's important profitability drivers and their relationship over time.

Use Augmedix in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Augmedix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Augmedix will appreciate offsetting losses from the drop in the long position's value.

Augmedix Pair Trading

Augmedix Pair Trading Analysis

The ability to find closely correlated positions to Augmedix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Augmedix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Augmedix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Augmedix to buy it.
The correlation of Augmedix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Augmedix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Augmedix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Augmedix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Augmedix position

In addition to having Augmedix in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run World Allocation Funds Thematic Idea Now

World Allocation Funds
World Allocation Funds Theme
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. The World Allocation Funds theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize World Allocation Funds Theme or any other thematic opportunities.
View All  Next Launch
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Augmedix Stock

If you are still planning to invest in Augmedix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Augmedix's history and understand the potential risks before investing.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance